Your browser doesn't support javascript.
loading
Prediction of the drug-drug interaction potential of the α1-acid glycoprotein bound, CYP3A4/CYP2C9 metabolized oncology drug, erdafitinib.
De Zwart, Loeckie; Snoeys, Jan; Jacobs, Frank; Li, Lilian Y; Poggesi, Italo; Verboven, Peter; Goris, Ivo; Scheers, Ellen; Wynant, Inneke; Monshouwer, Mario; Mamidi, Rao N V S.
Afiliación
  • De Zwart L; Janssen Research & Development, Beerse, Belgium.
  • Snoeys J; Janssen Research & Development, Beerse, Belgium.
  • Jacobs F; Janssen Research & Development, Beerse, Belgium.
  • Li LY; Janssen Research & Development, Spring House, Pennsylvania, USA.
  • Poggesi I; Janssen-Cilag SpA, Cologno Monzese, Italy.
  • Verboven P; Janssen Research & Development, Beerse, Belgium.
  • Goris I; Janssen Research & Development, Beerse, Belgium.
  • Scheers E; Janssen Research & Development, Beerse, Belgium.
  • Wynant I; Janssen Research & Development, Beerse, Belgium.
  • Monshouwer M; Janssen Research & Development, Beerse, Belgium.
  • Mamidi RNVS; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
CPT Pharmacometrics Syst Pharmacol ; 10(9): 1107-1118, 2021 09.
Article en En | MEDLINE | ID: mdl-34273250
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazoles / Quinoxalinas / Citocromo P-450 CYP3A / Citocromo P-450 CYP2C9 / Modelos Biológicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazoles / Quinoxalinas / Citocromo P-450 CYP3A / Citocromo P-450 CYP2C9 / Modelos Biológicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Bélgica